Edition:
India

Laurus Labs Ltd (LAUL.NS)

LAUL.NS on National Stock Exchange of India

345.75INR
20 Sep 2019
Change (% chg)

Rs5.50 (+1.62%)
Prev Close
Rs340.25
Open
Rs341.00
Day's High
Rs351.00
Day's Low
Rs341.00
Volume
23,782
Avg. Vol
30,978
52-wk High
Rs442.25
52-wk Low
Rs314.05

Latest Key Developments (Source: Significant Developments)

Laurus Labs Gets Establishment Inspection Report From US FDA For Parawada API Units
Thursday, 5 Sep 2019 

Sept 5 (Reuters) - Laurus Labs Ltd ::GETS ESTABLISHMENT INSPECTION REPORT FROM US FDA FOR API UNITS AT PARAWADA, VISAKHAPATNAM, FOR INSPECTION CONDUCTED IN JUNE 2019.IN FDF SEGMENT, GETS GLOBAL FUND EXPERT REVIEW PANEL APPROVAL FOR FIXED DOSE COMBINATION TLE 400 FOR SUPPLY IN GF FUNDED PROJECTS.  Full Article

India's Laurus Labs June-Qtr Profit Falls
Friday, 2 Aug 2019 

Aug 2 (Reuters) - Laurus Labs Ltd ::JUNE QUARTER NET PAT 150.6 MILLION RUPEES VERSUS 165.6 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 5.50 BILLION RUPEES VERSUS 5.39 BILLION RUPEES YEAR AGO.  Full Article

Laurus Labs Completes USFDA Inspection Of Visakhapatnam Unit Without Observations, No Form 483 Issued
Friday, 12 Jul 2019 

July 12 (Reuters) - Laurus Labs Ltd ::COMPLETED USFDA INSPECTION OF UNIT 4 AT VISAKHAPATNAM, ANDHRA PRADESH, WITHOUT ANY OBSERVATIONS AND NO FORM 483 ISSUED.  Full Article

Laurus Labs Completes U.S.FDA Inspection At Its API Facilities In Units 1 & 3
Friday, 14 Jun 2019 

June 14 (Reuters) - Laurus Labs Ltd ::COMPLETED US FOOD AND DRUG ADMINISTRATION (USFDA) INSPECTION OF ITS API FACILITIES IN UNITS 1 & 3.INSPECTION COMPLETED WITH TWO OBSERVATIONS WHICH ARE PROCEDURAL IN NATURE.  Full Article

India's Laurus Labs March-Qtr Profit Falls
Thursday, 2 May 2019 

May 2 (Reuters) - Laurus Labs Ltd ::MARCH QUARTER NET PAT 431.8 MILLION RUPEES VERSUS PROFIT 450.8 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 6.35 BILLION RUPEES VERSUS 5.60 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 1.50 RUPEES PER SHARE.  Full Article

Laurus Labs Says USFDA Issues One Observation For Unit 6 At Vishakapatnam
Friday, 2 Nov 2018 

Nov 2 (Reuters) - Laurus Labs Ltd ::LAURUS LABS - COMPLETED USFDA INSPECTION OF UNIT 6 API INTERMEDIATE FACILITY WITH ONE OBSERVATION WHICH IS RELATED TO A PROCEDURE, ON NOVEMBER 02.LAURUS LABS - MANUFACTURING FACILITY UNIT 6 IS LOCATED AT ATCHUTAPURAM IN VISAKHAPATNAM, ANDHRA PRADESH.  Full Article

India's Laurus Labs Sept-Qtr PAT Falls
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Laurus Labs Ltd ::SEPT QUARTER CONSOL NET PAT 162.1 MILLION RUPEES VERSUS PROFIT 487.6 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 5.88 BILLION RUPEES VERSUS 5.39 BILLION RUPEES YEAR AGO.  Full Article

Laurus Labs Says US FDA completed Unit 2 audit without observations
Thursday, 1 Mar 2018 

March 1 (Reuters) - Laurus Labs Ltd ::Says US FDA completed audit without observations at formulations Unit 2 from Feb 26 to March 1, 2018.  Full Article

Laurus labs gets EIR from US FDA for Visakhapatnam units
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Laurus Labs Ltd :Gets EIR from US FDA for unit 1, 3, at Parawada, Visakhapatnam, for inspection conducted in August 2017​.  Full Article

India's Laurus Labs Sept-qtr consol profit rises
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Laurus Labs Ltd ::Sept quarter consol net profit 487.6 million rupees versus 482.8 million rupees year ago.Sept quarter consol revenue from operations 5.39 billion rupees versus 5.25 billion rupees year ago.  Full Article

CARE ratings for Indian debt instruments-Jun 14

Jun 14 Below are the ratings awarded by Credit Analysis and Research Ltd. (CARE) for local debt instruments as of June 13, 2019. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------- ---------- ------ ------- --------- SHORT TERM RATINGS: ------------------- Allied Engineers (Karnal) ST Bk Fac